Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Altmeyer

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Research in Virology|April 30, 1998
Study of the immunogenicity of different recombinant Mengo viruses expressing HIV1 and SIV epitopesE Van der Ryst, T Nakasone, A Habel, et al.
The Journal of Biological Chemistry|May 16, 2001
Optimal inhibition of X4 HIV isolates by the CXC chemokine stromal cell-derived factor 1 alpha requires interaction with cell surface heparan sulfate proteoglycansA Valenzuela-Fernández, T Palanche, A Amara, et al.
Journal of Virology|August 30, 2008
The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particlesY L Siu, K T Teoh, J Lo, et al.
Scientific Reports|May 20, 2016
Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replicationB Bailly, C-A Richard, G Sharma, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|February 8, 2012
SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancementM Jaume, M S Yip, Y W Kam, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Research in Virology|April 30, 1998
Study of the immunogenicity of different recombinant Mengo viruses expressing HIV1 and SIV epitopesE Van der Ryst, T Nakasone, A Habel, et al.
The Journal of Biological Chemistry|May 16, 2001
Optimal inhibition of X4 HIV isolates by the CXC chemokine stromal cell-derived factor 1 alpha requires interaction with cell surface heparan sulfate proteoglycansA Valenzuela-Fernández, T Palanche, A Amara, et al.
Journal of Virology|August 30, 2008
The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particlesY L Siu, K T Teoh, J Lo, et al.
Scientific Reports|May 20, 2016
Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replicationB Bailly, C-A Richard, G Sharma, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|February 8, 2012
SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancementM Jaume, M S Yip, Y W Kam, et al.
Pageof 2